280. Huge arteriovenous malformation with cervicofacial or limb lesion Clinical trials / Disease details
Clinical trials : 27 / Drugs : 30 - (DrugBank : 15) / Drug target genes : 14 - Drug target pathways : 153
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04999618 (ClinicalTrials.gov) | January 1, 2020 | 17/7/2021 | A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology | DOUBLE-SKIN: a New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology: a Randomised, Double-blind, Placebo-controlled Trial | Vascular Diseases;Vascular Malformation;Capillary Malformation-Arteriovenous Malformation;Port-Wine Stain;Sturge-Weber Syndrome;Vascular Tumor | Drug: Haemoblock;Other: Placebo | Center for Vascular Pathology, Moscow | NULL | Completed | 6 Months | 18 Years | All | 200 | Phase 4 | Russian Federation |